Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function

Arntz, Pieter J W; Deroose, Christophe M; Marcus, Charles; Sturesson, Christian; Panaro, Fabrizio; Erdmann, Joris; Manevska, Nevena; Moadel, Renee; de Geus-Oei, Lioe-Fee; Bennink, Roel J

doi:10.1016/j.hpb.2023.06.001

Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function

Journal

HPB

Date Issued

2023-06-02

Author(s)

Arntz, Pieter J W

Deroose, Christophe M

Marcus, Charles

Sturesson, Christian

Panaro, Fabrizio

Erdmann, Joris

Moadel, Renee

de Geus-Oei, Lioe-Fee

Bennink, Roel J

DOI

10.1016/j.hpb.2023.06.001

Abstract

The aim of this joint EANM/SNMMI/IHPBA procedure guideline is to provide general information and specific recommendations and considerations on the use of [99mTc]Tc-mebrofenin hepatobiliary scintigraphy (HBS) in the quantitative assessment and risk analysis before surgical intervention, selective internal radiation therapy (SIRT) or before and after liver regenerative procedures. Although the gold standard to estimate future liver remnant (FLR) function remains volumetry, the increasing interest in HBS and the continuous request for implementation in major liver centers worldwide, demands standardization.